FDA-backed Pan-American info hub promises greater US market access
This article was originally published in Clinica
The US FDA is spearheading an Americas-wide project to improve the collection and use of regulatory and other market information related to all healthcare products.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.